New Study Shows Little Progress in Keeping Youth Away from Electronic Cigarettes in the United States

Oct.11.2022
New Study Shows Little Progress in Keeping Youth Away from Electronic Cigarettes in the United States
The latest study on youth vaping in the US shows little progress in preventing teens from using e-cigarettes.

A new study conducted by the US government on the use of e-cigarettes among youth has shown little progress in keeping teenagers away from vaping. The survey, which was released on Thursday, suggests that more high school students are using e-cigarettes, with 14% of them reporting recent use compared to 11% in the previous year.


However, experts warn that changes in the survey make comparisons difficult: this year, there is a much higher proportion of participants surveyed in schools, and there are often more reports of e-cigarette use in schools than at home. "Assessing trends (in e-cigarette use) since the outbreak of the pandemic remains difficult," said Alyssa Harlow, a researcher at the University of Southern California who studies adolescent e-cigarette use.


Although there are still many young people using e-cigarettes, they don't seem to be as popular as before. In 2019, 28% of high school students reported having recently used e-cigarettes. For educators, e-cigarettes remain a major issue.


Interestingly, the 2021-22 academic year is worse than pre-pandemic times, according to Mike Rinaldi, the principal of Westhill High School in Connecticut. He notes that it is the first year for many students returning from remote learning during the pandemic and speculates that some may have turned to e-cigarettes to cope with pandemic-related mental health issues or stress. Matt Forker, principal of Stamford High School, says that kids vaping in school bathrooms and stairwells remains a "persistent challenge".


Researchers from the Centers for Disease Control and Prevention authored a new study based on an online survey conducted from January 18th to May 31st of approximately 28,000 American high school students. The study inquired about the use of electronic cigarettes and other vaping devices in the past 30 days. In addition to 14% of high schoolers reporting recent use of e-cigarettes, around 3% of middle schoolers reported having tried them. Among those who used e-cigarettes, approximately 28% reported daily use. Nearly 85% of young people using e-cigarettes used flavored products, with Puff Bar and Vuse being the most popular brands followed by Hyde and Smok.


After months of pressure from congressional members and parents, the US Food and Drug Administration (FDA) took action against the manufacturers of Puff Bar and Hyde on Thursday. The agency sent a warning letter to Puff Bar manufacturer, EVO Brands, stating that the company had not obtained permission to sell their products in the US and that they were being illegally sold. Only a few e-cigarette companies have received FDA approval, which is only granted to products that are beneficial to the health of adult smokers.


The agency also stated that following the denial of their FDA authorization application, they have instructed Magellan Technology, the manufacturer of Hyde, to withdraw their product from the market.


The FDA has been working to regulate the extensive e-cigarette industry, which includes both established and start-up companies. Regulatory agencies have faced criticism from Congress and anti-e-cigarette advocates as they have missed multiple deadlines and have been unable to make decisions on compliance applications for millions of e-cigarette products submitted by companies.


In the past three years, federal and state laws and regulations have increased the purchasing age for tobacco and e-cigarette products, and have banned almost all small e-cigarette flavors that are popular among teenagers.


Some children may have also been scared away by the outbreak of illnesses and deaths related to e-cigarettes in 2019 - most of whom were associated with additives in black market e-liquids containing THC, a chemical that can produce a marijuana-like high when inhaled.


A leader of an advocacy organization has stated that their efforts to combat youth vaping have not been progressing well. These figures "may not reflect the larger reality of youth e-cigarette use that we hear about every day from parents, teachers, pediatricians, and prevention experts who are dealing with this urgent and ongoing youth public health crisis," said the organization, which is made up of parents opposed to vaping, in a statement.


Earlier this summer, the U.S. Food and Drug Administration (FDA) attempted to ban products from leading e-cigarette manufacturer Juul due to concerns about potential health risks. However, after a court challenge, the effort was forced to be put on hold. In a survey conducted this year, approximately one-fifth of teenage e-cigarette users reported using Juul recently, although it is no longer the most popular brand. This is a significant shift from 2019 when over half of young people's most commonly used e-cigarette was Juul.


On the contrary, many young people have turned to electronic cigarettes that offer laboratory-manufactured nicotine, including Puff Bar, which is a loophole in the FDA supervision that was shut down by Congress this year. Despite obtaining new authorization for these products, the FDA missed the mid-July deadline to make decisions on most products.


Statement:


This article is compiled from third-party information and is only intended for industry exchange and learning purposes.


This article does not reflect the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the article's content. The translation of this article is intended solely for industry exchange and research.


Due to limitations in translation abilities, the translated article may not accurately reflect the original text. Please refer to the original text for accuracy.


2FIRSTS aligns completely with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and international issues and positions.


The compilation of information is subject to the ownership of the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia’s withdrawal of its appeal in a landmark liquid-nicotine case has left a High Court ruling that struck down the 2023 nicotine exemption in force, bringing liquid and gel nicotine used in vaping products back under the Poisons Act 1952. At the same time, the Control of Smoking Products for Public Health Act 2024 continues to provide a regulatory framework for vaping products, creating uncertainty over retail sales, taxation and existing inventory. MPs are calling for nicotine vape sales and excise collection to stop, including refunds of more than RM354 million collected since 2023, while industry and consumer groups are asking the government to clarify the current legal position.
Sep.04
Reynolds Puts Nearly 183,000 U.S. Contracted Outlets Under Age-Verification Rules, Covering 94% of Volume — Can It Shift an Unauthorized Vape Market?
Reynolds Puts Nearly 183,000 U.S. Contracted Outlets Under Age-Verification Rules, Covering 94% of Volume — Can It Shift an Unauthorized Vape Market?
Reynolds American says nearly 183,000 U.S. retail outlets are under contract, with its Retail Marketing Plan Contract covering about 94% of company volume and requiring point-of-sale age verification. The company combines those contracts with We Card, TruAge, NACS-linked infrastructure and POS integration, while enhanced Vuse Pro retail rules add ID scanning, purchase limits and stronger underage-sales accountability. The initial Vuse Pro rollout targets about 50,000 stores. The system is taking shape as unauthorized vapor products remain dominant in parts of the U.S. market: a 2026 study estimated they accounted for 69.4% of tracked brick-and-mortar e-cigarette dollar sales in December 2025.
Special Report
Oct.15
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24